SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on January 6, 2016, reporting events occurring on January 4, 2016. The filing addresses a change in executive leadership within the company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial statements.
Material Changes
Effective January 4, 2016, Anne-Marie Ripley resigned from her position as Vice President, Regulatory & Clinical Affairs. Following her resignation, Ms. Ripley entered into a 12-month consulting agreement to provide services on an as-needed basis through December 31, 2016.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific risks. The only contingency noted is the transition of Ms. Ripley's role from full-time executive to consultant.
Investor Verification Checklist
- Confirm the effective date of Anne-Marie Ripley's resignation (January 4, 2016).
- Verify the terms of the new consulting agreement, specifically the 12-month duration ending December 31, 2016.
- Check for any subsequent filings regarding the appointment of a permanent replacement for the Vice President, Regulatory & Clinical Affairs role.